Recent evidence in individuals with and without AD pathology showed that increased levels of CSF TREM2 were associated with the slower amyloid accumulation, lower levels of tau (measured by PET scans) and cognitive decline, highlighting the protective functions of microglial in AD (46, 47). Here, MAPT is linked to Alzheimer disease.